Physician profile
Bakulkumar K Patel
NPI 1710932751
$2,388.99
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $181 · 2021: $396 · 2022: $400 · 2023: $591 · 2024: $134 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,205.00 | 2019-2025 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $466.26 | 2019-2023 | Shingrix, Bexsero |
| Lilly USA, LLC | $208.27 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $94.98 | 2021-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Exact Sciences Corporation | $76.76 | 2023-2025 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $53.36 | 2019 | Xyosted, Tlando |
| Pfizer INC. | $50.27 | 2022 | |
| Novo Nordisk INC | $49.39 | 2021-2025 | Ozempic, Rybelsus |
| Lucid Diagnostics INC. | $43.00 | 2022-2023 | |
| Abbvie INC. | $31.97 | 2021 | |
| Halozyme INC | $30.60 | 2023 | |
| Inari Medical, INC. | $29.23 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biosense Webster, INC. | $24.75 | 2021 | |
| Sk Life Science, INC. | $13.19 | 2024 | |
| Antares Pharma, INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bakulkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.